Math Over Myth: Psychedelic Stock HAVN Life Collapses
The psychedelic corporate shakeout continues as another company, HAVN Life Sciences, folds due to lack of cash flow
The psychedelic corporate shakeout continues as another company, HAVN Life Sciences, folds due to lack of cash flow
Delic establishes medical board to oversee psychedelic treatment protocols, cool new delivery systems investigated for psychedelics, and VR meets psychedelic therapies, finally.
This week in psychedelic business news: More psychedelic-assisted therapy clinics, recruitment begins in early DMT trial, and Filament gets more Health Canada love.
The global supply chain of regulated psilocybin and ibogaine continues to grow as these Canadian companies beef up manufacturing efforts.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.